尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体
Monoclonal Antibody to Plasminogen Activator, Urokinase Receptor (uPAR)
CD87; PLAUR; PLAU-R; U-PAR; URKR; Monocyte Activation Antigen Mo3
- 编号MAA141Ra22
- 物种Rattus norvegicus (Rat，大鼠)相同的名称，不同的物种。
- 来源单抗制备
- 宿主小鼠
- 效价(克隆号)C3
- Ig亚型 IgG2a Kappa
- 纯化方式蛋白A + 蛋白G亲和纯化
- 标记物无标记物
- 免疫原RPA141Ra01-尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性状液体
- 浓度1mg/ml
- 且适物种Homo sapiens (Human，人)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载英文说明书 中文说明书
- 规格20µl100µl200µl1ml10ml
- 价格¥ 661¥ 1541¥ 2202¥ 5505¥ 22020
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
Western Blot; Sample: Lane1: Rat Cerebrum lysate; Lane2: Rat Placenta lysate; Lane3: A431 cell lysate; Lane4: SKOV3 cell lysate Primary Ab: 1µg/ml Mouse Anti-Rat uPAR Antibody Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对uPAR的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别uPAR。
用法
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Rattus norvegicus (Rat，大鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA141Ra01 | 尿激酶型纤溶酶原激活因子受体(uPAR)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA141Ra01 | 尿激酶型纤溶酶原激活因子受体(uPAR)活性蛋白 | Cell culture; Activity Assays. |
| PAA141Ra01 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA141Ra71 | 尿激酶型纤溶酶原激活因子受体(uPAR)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAA141Ra23 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA141Ra21 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA141Ra24 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB |
| MAA141Ra22 | 尿激酶型纤溶酶原激活因子受体(uPAR)单克隆抗体 | WB; IHC; ICC; IP. |
| SEA141Ra | 尿激酶型纤溶酶原激活因子受体(uPAR)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA141Ra | 尿激酶型纤溶酶原激活因子受体(uPAR)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| International Journal of Cancer | Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice[Wiley: source] |
| Biomark Insights | Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism[PubMed: PMC3623607] |
| Biomarker insights | Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD)[PubMed: PMC3762604] |
| Am J Emerg Med | Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis[PubMed: 26615223] |
| Archives of Clinical Infectious Diseases | Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis[Archcid: 26346] |
| The American Journal of Emergency Medicine | Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic Cavia (Guinea pig )idance of sepsis[science:S0735675715009559] |
| Journal of Clinical and Experimental Hepatology | Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) …[10.1016:j.jceh.2018.02.001] |
| Turkish journal of trauma & emergency surgery | The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis[Pubmed: 31475329] |
| CELL TRANSPLANTATION | Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction[33787356] |